Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.

作者: M. Imbesi , T. Uz , H. Manev

DOI: 10.1016/J.NEUROSCIENCE.2008.06.058

关键词: K252aReceptorAgonistMelatonin receptor agonistEndocrinologyRamelteonLuzindoleMelatonin receptorInternal medicineBiologyTrk receptor

摘要: The melatonin receptors MT1 and MT2 take part in the regulation of activity (i.e. phosphorylation) extracellular-signal-regulated kinase (ERK1/2), an enzyme involved neuroplasticity. Primary cultures mouse rat cerebellar granule cells (CGC), which express both receptors, have been widely used as vitro model to study neuronal ERK1/2. A novel MT1/MT2 agonist, ramelteon, has recently become clinically available. In this study, we characterized its action on We CGC prepared from cerebella wild-type mice (MT1/MT2 CGC) MT1- MT2-knockout (KO) (MT1 KO CGC, respectively), employed a Western blot assay evaluate ERK1/2 phosphorylation. Ramelteon increased phosphorylation not only but also expressing one two receptors. stimulatory effect ramelteon was blocked by antagonist, 4P-PDOT, whereas luzindole. Pertussis toxin treatment did prevent activating pretreatment with tyrosine (Trk) inhibitor, K252a, did, suggesting that activation Trk may mediate melatonin-receptor dependent activation. conclusion, showed for first time is capable

参考文章(30)
Tolga Uz, Ahmet D Arslan, Hari Manev, Sevim Yildiz, Marta Imbesi, Drug- and region-specific effects of protracted antidepressant and cocaine treatment on the content of melatonin MT(1) and MT(2) receptor mRNA in the mouse brain. International journal of neuroprotection and neuroregeneration. ,vol. 2, pp. 185- 189 ,(2006)
Margarita L Dubocovich, Moises A Rivera-Bermudez, Matthew J Gerdin, Monica I Masana, Molecular pharmacology, regulation and function of mammalian melatonin receptors. Frontiers in Bioscience. ,vol. 8, ,(2003) , 10.2741/1089
M J Thomas, P W Kalivas, Y Shaham, Neuroplasticity in the mesolimbic dopamine system and cocaine addiction British Journal of Pharmacology. ,vol. 154, pp. 327- 342 ,(2009) , 10.1038/BJP.2008.77
Margarita L. Dubocovich, Kenneth Yun, Walid M. Al‐Ghoul, Susan Benloucif, Monica I. Masana, Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms The FASEB Journal. ,vol. 12, pp. 1211- 1220 ,(1998) , 10.1096/FASEBJ.12.12.1211
C. Dominic Bondi, Raelene M. McKeon, Jennifer M. Bennett, Paul F. Ignatius, Lena Brydon, Ralf Jockers, Melissa A. Melan, Paula A. Witt-Enderby, MT1 melatonin receptor internalization underlies melatonin-induced morphologic changes in Chinese hamster ovary cells and these processes are dependent on Gi proteins, MEK 1/2 and microtubule modulation. Journal of Pineal Research. ,vol. 44, pp. 288- 298 ,(2008) , 10.1111/J.1600-079X.2007.00525.X
Koki Kato, Keisuke Hirai, Keiji Nishiyama, Osamu Uchikawa, Kohji Fukatsu, Shigenori Ohkawa, Yuji Kawamata, Shuji Hinuma, Masaomi Miyamoto, Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist. Neuropharmacology. ,vol. 48, pp. 301- 310 ,(2005) , 10.1016/J.NEUROPHARM.2004.09.007
A.M.S. Poon, G.M. Kravtsov, S.F. Pang, Receptor‐mediated modulation of avian caecal muscle contraction by melatonin: role of tyrosine protein kinase Journal of Pineal Research. ,vol. 32, pp. 199- 208 ,(2002) , 10.1034/J.1600-079X.2002.1O857.X
Gabriel F Anhê, Luciana C Caperuto, Marcio Pereira‐Da‐Silva, Lilian C Souza, A Emiko Hirata, Lício A Velloso, José Cipolla‐Neto, Carla RO Carvalho, None, In vivo activation of insulin receptor tyrosine kinase by melatonin in the rat hypothalamus Journal of Neurochemistry. ,vol. 90, pp. 559- 566 ,(2004) , 10.1111/J.1471-4159.2004.02514.X